Your browser doesn't support javascript.
loading
Evaluating the experiences of individuals with personal health risks identified through expanded carrier screening.
Brown, Emily M; Grinzaid, Karen A; Ali, Nadia; Mehta, Nikita; Hardy, Melanie W.
Afiliação
  • Brown EM; Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Grinzaid KA; Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Ali N; Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Mehta N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Hardy MW; Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.
J Genet Couns ; 31(3): 598-607, 2022 06.
Article em En | MEDLINE | ID: mdl-34695254
ABSTRACT
Expanded carrier screening (ECS) is used to identify individuals and couples at risk for having children with recessive or X-linked genetic conditions; however, personal health risks (PHR) can also be identified through this testing. There is limited data on how genetic counseling regarding PHR from ECS is perceived by the individual, or how they use this information. This study quantitatively surveyed individuals identified with these risks between September 2013 and March 2020. The 30-item survey included the validated Genomics Outcome Scale Short Form, the validated Genetic Counseling Satisfaction Scale, and original questions. Survey topics included pre-test knowledge of the possibility of discovering PHR through testing, satisfaction with pre-test education that addresses potential risks, perceived severity of PHR, empowerment by and understanding of information, anxiety levels related to their PHR, perceived genetic counseling support, and satisfaction with telehealth. A total of 416 completed surveys were analyzed using descriptive statistics, and linear and logistic regressions. The majority of participants were satisfied or extremely satisfied with pre-test education (n = 328; 78.8%) and telehealth (n = 329; 79.1%). However, more participants who were aware of the possibility of identifying PHR through ECS prior to testing were satisfied with pre-test education compared to those who were not aware. Additionally, a lack of prior awareness of PHR was associated with lower empowerment scores (p = .004). Those who were highly satisfied with genetic counseling were more likely to feel empowered and understand the information presented (p = .001). The majority of individuals used their PHR information following their results appointment (n = 391; 94.0%). The results of this study suggest that receiving PHR information was useful and was positively influenced by both pre-test education and the genetic counseling process.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / Aconselhamento Genético Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / Aconselhamento Genético Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article